Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
Cancers|May 28, 2022
Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus ExerciseMirco Bartolomei, Alfredo Berruti, Massimo Falconi, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 20, 2024
Challenging diagnosis of resistance to thyroid hormone in a patient with COVID-19, pituitary microadenoma and unusual response to octreotide long-acting release testCristian Petolicchio, Sara Brasili, Stefano Gay, et al.
Endocrine|April 15, 2016
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patientsMara Boschetti, Sergio Agosti, Valeria Albanese, et al.
Journal of Virological Methods|May 31, 2021
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnosticAndrea Orsi, Beatrice Marina Pennati, Bianca Bruzzone, et al.
BMC Endocrine Disorders|January 11, 2023
Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-upMarta Franco, Keyvan Khorrami Chokami, Manuela Albertelli, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2008
Computed tomography colonography in acromegalyEugenia Resmini, Alberto Tagliafico, Lorenzo Bacigalupo, et al.
Clinical Endocrinology|December 20, 2008
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegalyAnnamaria Colao, Renata S Auriemma, Alberto Rebora, et al.
International Journal of Endocrinology|December 9, 2014
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 SystemFederica Barbieri, Stefano Thellung, Roberto Würth, et al.
Pituitary|November 29, 2018
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cellsFederico Gatto, Marica Arvigo, Jessica Amarù, et al.
Pageof 18